Provided by Tiger Trade Technology Pte. Ltd.

Regulus Therapeutics

8.16
0.0000
Volume:- -
Turnover:75.91M
Market Cap:564.95M
PE:-11.28
High:8.16
Open:8.16
Low:8.16
Close:8.16
52wk High:8.35
52wk Low:0.8301
Shares:69.23M
Float Shares:52.94M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7233
EPS(LYR):-0.8227
ROE:-53.82%
ROA:-34.23%
PB:8.18
PE(LYR):-9.92

Loading ...

Aug 06, 2019

Major Issues Report

Current report, items 5.02, 5.07, and 9.01
Jul 30, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Jul 25, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 24, 2019

Major Issues Report

Current report, items 1.01 and 1.02
Jun 12, 2019

Correspondence

[Cover]Correspondence
Jun 12, 2019

Major Issues Report

Current report, item 5.02
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
May 17, 2019

Major Issues Report

Current report, item 5.02
May 15, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
May 15, 2019

Major Issues Report

Current report, item 8.01
May 10, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 09, 2019

Major Issues Report

Current report, items 1.01, 2.02, 3.02, 5.03, 8.01, and 9.01
Apr 29, 2019

[Rev.]Annual Report

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 06, 2018

Correspondence

Nov 08, 2017

Major Issues Report

轩辕十四疗法公司。
Jun 14, 2016

Major Issues Report